Edition:
United Kingdom

Taisho Pharmaceutical Holdings Co Ltd (4581.T)

4581.T on Tokyo Stock Exchange

9,400JPY
24 May 2019
Change (% chg)

¥30 (+0.32%)
Prev Close
¥9,370
Open
¥9,290
Day's High
¥9,420
Day's Low
¥9,290
Volume
150,200
Avg. Vol
107,830
52-wk High
¥14,130
52-wk Low
¥9,130

About

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. is a holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Self-Medication segment is engaged in the research, development, manufacture and sale of general pharmaceuticals, general foods, medical supplies and others. The Medical segment is engaged in the... (more)

Overall

Beta: 0.46
Market Cap(Mil.): ¥847,312.81
Shares Outstanding(Mil.): 90.14
Dividend: 50.00
Yield (%): 1.17

Financials

  4581.T Industry Sector
P/E (TTM): 15.45 31.17 35.48
EPS (TTM): 608.30 -- --
ROI: 6.75 12.05 11.75
ROE: 7.00 13.36 16.52

Bristol-Myers gets $1.6 billion offer for French consumer health unit

Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

19 Dec 2018

UPDATE 2-Bristol-Myers gets $1.6 bln offer for French consumer health unit

Dec 19 Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

19 Dec 2018

Bristol-Myers gets $1.6 billion offer for French consumer health unit

Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion (1.3 billion pounds), the companies said on Wednesday.

19 Dec 2018

Bristol-Myers gets $1.6 bln offer for French consumer health unit

Dec 19 Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

19 Dec 2018

Deals of the day-Mergers and acquisitions

Dec 17 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Monday:

17 Dec 2018

Taisho said to near $1.6 billion deal for Bristol-Myers's UPSA - Bloomberg

Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a $1.6 billion (1.3-billion pound) deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.

17 Dec 2018

Taisho said to near $1.6 billion deal for Bristol-Myers's UPSA: Bloomberg

Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a $1.6 billion deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.

17 Dec 2018

Taisho said to near $1.6 bln deal for Bristol-Myers's UPSA- Bloomberg

Dec 16 Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a $1.6 billion deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.

17 Dec 2018

Earnings vs. Estimates